Results 21 to 30 of about 52,263 (284)

Identification of Predictive Factors for Isolated Brain Progression in Patients With Cerebral Metastatic Melanoma After Treatment With Stereotactic Brain Radiotherapy

JEADV Clinical Practice
Background Melanomas often metastasize to the brain, leading to a significantly poor prognosis despite advances in local and systemic treatments. In clinical practice, we frequently observe varying response patterns and progression dynamics between ...
Manuel Croix, Justine Lequesne, Julien Geffrelot, Anne Dompmartin, Jean Matthieu L'orphelin   +4 more
doaj   +2 more sources

Stereotactic radiosurgery and radiotherapy in complex treatment of patients with intracranial pilocytic astrocytomas

, 2023
The paper reports the analysis of the stereotactic irradiation outcomes in 430 patients with pilocytic astrocytomas (PAs), who underwent treatment in 2005–2018. The comprehensive approach to treatment of patients with intracranial pilocytic astrocytomas (
Leonid B. Likhterman, Ruslan I. Zagirov, Andrey V. Golanov, Yury Yu. Trunin, Alexander N. Konovalov, Igor N. Pronin   +5 more
core   +1 more source

Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003 - a single institution's experience [PDF]

, 2010
Background: To evaluate the effectivity of fractionated radiotherapy in adolescent and adult patients with pineal parenchymal tumors (PPT). Methods: Between 1982 and 2003, 14 patients with PPTs were treated with fractionated radiotherapy.
Schulz-Ertner Daniela, Stoiber Eva, Herfarth, Klaus, Klaus Herfarth, Schaible, Benjamin, Debus Jürgen, Daniela Schulz-Ertner, Peter E Huber, Stoiber, Eva Maria, Huber, Peter E., Jürgen Debus, Herfarth Klaus, Susanne Oertel, Schaible Benjamin, Eva Stoiber, Eva Maria Stoiber, Debus, Jürgen, Oertel Susanne, Oertel, Susanne, Benjamin Schaible, Schulz-Ertner, Daniela, Huber Peter E   +21 more
core   +1 more source

Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors

Frontiers in Oncology, 2019
Background: Significantly better local control is achieved with combination of whole brain radiotherapy and stereotactic radiosurgery in the treatment of multiple brain metastases.
Muhammad Khan, Muhammad Khan, Jie Lin, Guixiang Liao, Yunhong Tian, Yingying Liang, Rong Li, Mengzhong Liu, Mengzhong Liu, Yawei Yuan   +9 more
doaj   +1 more source

Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial

BMC Cancer, 2023
Background The brain is a common site for cancer metastases. In case of large and/or symptomatic brain metastases, neurosurgical resection is performed.
Maria Waltenberger, Denise Bernhardt, Christian Diehl, Jens Gempt, Bernhard Meyer, Christoph Straube, Benedikt Wiestler, Jan J. Wilkens, Claus Zimmer, Stephanie E. Combs   +9 more
doaj   +1 more source

Stereotactic radiotherapy for liver oligometastases

Reports of Practical Oncology and Radiotherapy, 2022
The liver is the first metastatic site in 15-25% of colorectal cancer patients and one of the first metastatic sites for lung and breast cancer patients. A computed tomography (CT ) scan with contrast medium is a standard procedure for assessing liver lesions but magnetic resonance imaging (MRI) characterizes small lesions better thanks to its high ...
Menichelli, Claudia, Casamassima, Franco, Aristei, Cynthia, Ingrosso, Gianluca, Borghesi, Simona, Arcidiacono, Fabio, Lancellotta, Valentina, Franzese, Ciro, Arcangeli, Stefano   +8 more
openaire   +2 more sources

Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).

, 2022
PURPOSE Preoperative stereotactic radiosurgery (SRS) of brain metastases may achieve similar local control and better leptomeningeal control rates than postoperative fractionated stereotactic radiotherapy (FSRT) in patients treated with elective ...
Boström, J, Minasch, D, Exner, S, Temming, S, Wittig, A, Blanck, O, Mai, S, Rogers, S, Riesterer, O, Lux, S, Engenhart-Cabillic, R, Combs, S, Combs, S E, Ermis, E, Habermehl, D, Hemmatazad, H, Zweifel, C, Guckenberger, M, Rezazadeh, A, Henke, G, Böhmer, D, Steffal, C, Baumert, B, Lohaus, F   +23 more
core   +1 more source

SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases [PDF]

, 2023
Background: Stereotactic radiosurgery (SRS) is a frequently chosen treatment for patients with brain metastases and the number of long-term survivors is increasing. Brain necrosis (e.g.
Crouzen, J. A., Franssen, J. H., Broekman, M.L.D., Petoukhova, A. L., Zindler, J. D., Petoukhova, A.L., Sande, M.A.E. van de, Rij, C.M. van, Vos, M. J., Crouzen, J.A., Kerkhof, M., van de Sande, M. A.E., van der Toorn, P. P.G., Wiltink, L. M., Hooijdonk, C.G.M.G.V., Fisscher, U.J., Vos, M.J., Tewarie, R.N., Zyp, N.C.M.G.V. van, van Rij, C. M., Fisscher, U. J., Wiggenraad, R. G.J., van der Voort van Zyp, N. C.M.G., Wiggenraad, R.G.J., Nandoe Tewarie, R., Toorn, P.P.G. van der, Mast, M.E., Fiocco, M., Broekman, M. L.D., Franssen, J.H., Wiltink, L.M., Zindler, J.D., Gadellaa-van Hooijdonk, C. G.M., Vlasman, R., Kiderlen, M., Mast, M. E.   +35 more
core   +1 more source

The experience of stereotactic radiosurgery and radiotherapy use in combined treatment of pituitary adenomas

Ukrainian Neurosurgical Journal, 2015
Introduction. Pituitary tumors take the third place in a structure of CNS neoplasms and ranged from 4 to 17% of all brain tumors.The purpose.
Andrey Gryazov, Olga Chuvashova, Nikolay Guk, Aleksandr Guk, Yuliya Medvedovskaya, Elena Andriychenko, Vitaliy Zakordonets   +6 more
doaj   +1 more source

Stereotactic radiotherapy for intrahepatic cholangiocarcinoma

World Journal of Gastrointestinal Oncology, 2022
Intrahepatic cholangiocarcinoma (iCCA) is an aggressive malignancy with an increasing incidence worldwide and poor prognosis, despite several advances and continuous efforts to develop effective treatments. Complete surgical resection is the mainstay of treatment and offers a potentially curative option, but is only possible in less than a third of ...
Borakati, Aditya, Froghi, Farid, Bhogal, Ricky H, Mavroeidis, Vasileios K   +3 more
openaire   +2 more sources